Prostate-Specific Natural Health Products (Dietary Supplements) Radiosensitize Normal Prostate Cells

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 896-904

  Hasan, Yasmin ^a   Schoenherr, Diane ^a   Martinez, Alvaro A ^a   Wilson, George D ^a   Marples, Brian ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Dietary supplements; Ionizing radiation; Prostate; Radiosensitivity

Indexed keywords

APOPTOSIS; CANCER PATIENTS; CASPASE-3 ACTIVATION; CELL CYCLE; CELLULAR RADIOSENSITIVITY; CLONOGENIC ASSAYS; COMMERCIAL SOURCES; DIETARY SUPPLEMENTS; DNA REPAIR; HEALTH PRODUCTS; INHIBITION OF DNA REPAIR; LNCAP CELLS; PROSTATE CANCER CELLS; PROSTATE CELLS; PROSTATE TUMOR; PULSE-LABELING; RADIO-SENSITIZATION;

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; DNA; FOOD ADDITIVES; GENES; GROWTH KINETICS; HEALTH; IONIZING RADIATION; NUTRITION; PRESSURIZED WATER REACTORS; RADIATION SHIELDING; RADIOACTIVITY; RADIOTHERAPY;

VITAMINS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; BROXURIDINE; CASPASE 3; HERBACEOUS AGENT; HISTONE H2AX; PROPIDIUM IODIDE; PROSTATE RX; PROVELEX; TRINOVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; RADIOSENSITIVITY; RADIOSENSITIZATION;

BIOLOGICAL PRODUCTS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DIETARY SUPPLEMENTS; EPITHELIAL CELLS; HUMANS; MALE; ORGAN SPECIFICITY; PROSTATE; PROSTATIC NEOPLASMS; RADIATION TOLERANCE;

EID: 76049123758     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.048     Document Type: Article

References (33)

1. Shimizu H., Ross R.K., Bernstein L., et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63 (1991) 963-966
2. Moyad M.A. The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy: Part II-Rapid review of dietary supplements. Curr Opin Urol 13 (2003) 147-151
3. Moyad M.A., and Carroll P.R. Lifestyle recommendations to prevent prostate cancer, part II: Time to redirect our attention?. Urol Clin North Am 31 (2004) 301-311
4. Moyad M.A., and Carroll P.R. Lifestyle recommendations to prevent prostate cancer, part I: Time to redirect our attention?. Urol Clin North Am 31 (2004) 289-300
5. Davies A.A., Davey Smith G., Harbord R., et al. Nutritional interventions and outcome in patients with cancer or preinvasive lesions: Systematic review. J Natl Cancer Inst 98 (2006) 961-973
6. Ladas E.J., Jacobson J.S., Kennedy D.D., et al. Antioxidants and cancer therapy: A systematic review. J Clin Oncol 22 (2004) 517-528
7. Diefenbach M.A., Hamrick N., Uzzo R., et al. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol 170 (2003) 166-169
8. Hall J.D., Bissonette E.A., Boyd J.C., et al. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: Results of a pilot study. BJU Int 91 (2003) 603-607
9. Schroder F.H., Roobol M.J., Boeve E.R., et al. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: Effectiveness of a dietary supplement. Eur Urol 48 (2005) 922-930 921
10. Bent S., Kane C., Shinohara K., et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 354 (2006) 557-566
11. Velicer C.M., and Ulrich C.M. Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review. J Clin Oncol 26 (2008) 665-673
12. D'Andrea G.M. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55 (2005) 319-321
13. Kubota T., Hisatake J., Hisatake Y., et al. PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. Prostate 42 (2000) 163-171
14. Markowitz J.S., Donovan J.L., DeVane C.L., et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290 (2003) 1500-1504
15. Mathijssen R.H., Verweij J., de Bruijn P., et al. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 94 (2002) 1247-1249
16. Leadon S.A. Repair of DNA damage produced by ionizing radiation: A minireview. Semin Radiat Oncol 6 (1996) 295-305
17. Wilson G.D. Cell kinetic studies using a monoclonal antibody to bromodeoxyuridine. Methods Mol Biol 80 (1998) 255-266
18. Olive P.L., and Banath J.P. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 58 (2004) 331-335
19. Prasad K.N. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 134 (2004) 3182S-3183S
20. Chan J.M., Gann P.H., and Giovannucci E.L. Role of diet in prostate cancer development and progression. J Clin Oncol 23 (2005) 8152-8160
21. Block K.I. Antioxidants and cancer therapy: Furthering the debate. Integr Cancer Ther 3 (2004) 342-348
22. Sparber A., Jonas W., White J., et al. Cancer clinical trials and subject use of natural herbal products. Cancer Invest 18 (2000) 436-439
23. Brown P.J., and Carney P.A. Health beliefs and alternative medicine: A qualitative study of breast cancer patients. J Cancer Educ 11 (1996) 226-229
24. Swarup A.B., Barrett W., and Jazieh A.R. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol 29 (2006) 468-473
25. Astin J.A. Why patients use alternative medicine: results of a national study. JAMA 279 (1998) 1548-1553
26. Bostwick D.G., Cooner W.H., Denis L., et al. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70 (1992) 291-301
27. Barnes P.M., Powell-Griner E., McFann K., et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 27 (2004) 1-19
28. Veltri R.W., Marks L.S., Miller M.C., et al. Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: Evidence for a possible molecular mechanism. Urology 60 (2002) 617-622
29. Wilt T., Ishani A., and MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev (2002) CD001423
30. Webber M.M., Bello D., Kleinman H.K., et al. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 17 (1996) 1641-1646
31. Neuhouser M.L., Barnett M.J., Kristal A.R., et al. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 18 (2009) 2202-2206
32. Poon K.S., and McVary K.T. Dietary patterns, supplement use, and the risk of benign prostatic hyperplasia. Curr Urol Rep 10 (2009) 279-286
33. Ma R.W., and Chapman K. A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet 22 (2009) 187-199 quiz 200, 182